Aducanumab Biosimilar – Anti-APP Abeta mAb – Research Grade

Reference:
Size

,

Brand

Product type

Clonality

Expression system

Applications

,

Product nameAducanumab Biosimilar - Anti-APP Abeta mAb - Research Grade
SourceCAS 1384260-65-4
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsAducanumab,BART,BIIB-037,APP Abeta,anti-APP Abeta
ReferencePX-TA1335
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

General information on Anti-APP Abeta[Homo sapiens] (Aducanumab) Monoclonal Antibody

Aducanumab has been investigated for the treatment of Alzheimer’s Disease.

SDS-PAGE for Aducanumab Biosimilar - Anti-APP Abeta mAb

Aducanumab Biosimilar - Anti-APP Abeta mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Aducanumab Biosimilar – Anti-APP Abeta mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human APP (18-690) Recombinant Protein
Antigen Human APP (18-690) Recombinant Protein PX-P1058 210€
Human APP (18-705) Recombinant Protein
Antigen Human APP (18-705) Recombinant Protein PX-P1059 210€
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control Human IgG1 LALA Isotype Control antibody (HyHEL-10) PTX17885-100 180€
Stable Istotope Labelled Aducanumab Biosimilar – Anti-APP  Abeta mAb – Research Grade
SIL Stable Istotope Labelled Aducanumab Biosimilar – Anti-APP Abeta mAb – Research Grade PX-TA1335-SIL 1500€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.